World's Best Scientists 2026 revealed!

D-Index & Metrics

Best Scientists

D-Index
165
Citations
107398
World Ranking
1043
National Ranking
618

Medicine

D-Index
168
Citations
112070
World Ranking
567
National Ranking
330

Dan M. Roden publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dan M. Roden sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,096 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dan M. Roden D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dan M. Roden sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 168 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Dan M. Roden is affiliated with Vanderbilt University Medical Center in the United States. Their research spans medicine, biochemistry, genetics, and molecular biology, with a particular focus on cardiology and cardiovascular medicine, molecular biology, genetics, hematology, and physiology.

The scientist's work covers numerous topical areas, including:

  • Cardiac electrophysiology and arrhythmias
  • Genomics and rare diseases
  • Cardiomyopathy and myosin studies
  • Genetic associations and epidemiology
  • Ion channel regulation and function
  • RNA and protein synthesis mechanisms
  • BRCA gene mutations in cancer

Dan M. Roden has published extensively in several key venues. Frequent publication outlets include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Circulation
  • Heart Rhythm
  • Nature Communications
  • Circulation Genomic and Precision Medicine

Their recent notable papers include:

  • "Genomic data in the All of Us Research Program," published in 2024 in Nature
  • "Predictive Accuracy of a Polygenic Risk Score Compared With a Clinical Risk Score for Incident Coronary Heart Disease," published in 2020 in JAMA
  • "The All of Us Research Program: Data quality, utility, and diversity," published in 2022 in Patterns
  • "The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms," published in 2022 in Clinical Pharmacology & Therapeutics
  • "Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment," published in 2020 in Circulation

Throughout their career, Dan M. Roden has frequently collaborated with colleagues including:

  • M. Benjamin Shoemaker
  • Andrew M. Glazer
  • Quinn S. Wells
  • Matthew J. O'Neill
  • Giovanni Davogustto

Dan M. Roden has contributed to over 346 publications in medicine and 230 in biochemistry, genetics, and molecular biology. Their work notably intersects with cardiology and cardiovascular medicine with 187 publications, and molecular biology with 116 publications. Genetic research, hematology, and physiology also form significant components of their portfolio.

In recognition of their work, the scientist was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2012.

Best Publications

  • ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)

    Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton

  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade

    Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

  • Drug-induced prolongation of the QT interval.

    Dan M. Roden

  • Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.

    Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson

  • Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

    Bruce L. Wilkoff;James R. Cook;Andrew E. Epstein;Leon Greene

  • Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita. Versión resumida.

    Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton

  • Estimation of the warfarin dose with clinical and pharmacogenetic data

    Klein Te;Altman Rb;Eriksson N

  • PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.

    Joshua C. Denny;Marylyn D. Ritchie;Melissa A. Basford;Jill M. Pulley

  • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

    R. B. Kim;M. F. Fromm;C. Wandel;B. Leake

  • Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data

    Joshua C. Denny;Lisa Bastarache;Marylyn D. Ritchie;Robert J. Carroll

  • A structural variation reference for medical and population genetics

    Ryan L Collins;Ryan L Collins;Harrison Brand;Harrison Brand;Konrad J Karczewski;Konrad J Karczewski;Xuefang Zhao;Xuefang Zhao

  • Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

    Barbara J. Drew;Michael John Ackerman;Marjorie Funk;W. Brian Gibler

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

    Scott Sa;Sangkuhl K;Stein Cm;Hulot Js;Hulot Js

  • Development of a large-scale de-identified DNA biobank to enable personalized medicine.

    DM Roden;JM Pulley;MA Basford;GR Bernard

  • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton

  • Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

    Joe-Elie Salem;Joe-Elie Salem;Ali Manouchehri;Melissa Moey;Bénédicte Lebrun-Vignes

  • Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.

    Dan M. Roden;Ralph Lazzara;Michael Rosen;Peter J. Schwartz

  • TAKING THE IDIO OUT OF IDIOSYNCRATIC : PREDICTING TORSADES DE POINTES

    Dan M. Roden

  • Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

    Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson

  • Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

    Douglas P Zipes;A John Camm;Martin Borggrefe;Alfred E Buxton

Frequent Co-Authors

Joshua C. Denny
Joshua C. Denny National Institutes of Health
Marylyn D. Ritchie
Marylyn D. Ritchie University of Pennsylvania
Patrick T. Ellinor
Patrick T. Ellinor Harvard University
Richard B. Kim
Richard B. Kim University of Western Ontario
Steven A. Lubitz
Steven A. Lubitz Harvard University
Alfred L. George
Alfred L. George Northwestern University
Dana C. Crawford
Dana C. Crawford Case Western Reserve University
David N. Juurlink
David N. Juurlink University of Toronto
Bruce M. Psaty
Bruce M. Psaty University of Washington
Gail P. Jarvik
Gail P. Jarvik University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine extends beyond traditional medical school. Many students begin their journeys with related online degrees, which can open doors to a variety of career paths in healthcare. These programs are ideal for those seeking flexibility, affordability, or a stepping stone toward a higher credential.

Prospective nurses often look for options such as cheap online nursing programs, which make entering the field more accessible. If you are already an RN, consider advancing your skills with the cheapest rn to bsn program to increase your earning potential and job opportunities.

Those interested in specialized practice can benefit from the cheapest fnp programs to become a Family Nurse Practitioner with minimal debt. For those aiming for leadership or academic roles, phd in nursing online programs offer a flexible path to advanced expertise.

By choosing affordable and accredited online options, you can find a career pathway that matches your goals—whether at the bedside, in clinics, or as a healthcare leader.

Best Scientists Citing Dan M. Roden

Trending Scientists

Recently Published Articles